- Home
- CPIX vs AVTE Comparison
CPIX vs AVTE Comparison
Compare CPIX & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- AVTE
- Stock Information
- Founded
- CPIX 1999
- AVTE 2018
- Country
- CPIX United States
- AVTE United States
- Employees
- CPIX N/A
- AVTE N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- AVTE Health Care
- Exchange
- CPIX Nasdaq
- AVTE Nasdaq
- Market Cap
- CPIX 68.7M
- AVTE 72.5M
- IPO Year
- CPIX 2009
- AVTE 2021
- Fundamental
- Price
- CPIX $4.22
- AVTE $2.51
- Analyst Decision
- CPIX
- AVTE Hold
- Analyst Count
- CPIX 0
- AVTE 7
- Target Price
- CPIX N/A
- AVTE $11.75
- AVG Volume (30 Days)
- CPIX 131.8K
- AVTE 62.3K
- Earning Date
- CPIX 03-04-2025
- AVTE 03-27-2025
- Dividend Yield
- CPIX N/A
- AVTE N/A
- EPS Growth
- CPIX N/A
- AVTE N/A
- EPS
- CPIX N/A
- AVTE N/A
- Revenue
- CPIX $37,867,945.00
- AVTE N/A
- Revenue This Year
- CPIX N/A
- AVTE N/A
- Revenue Next Year
- CPIX N/A
- AVTE N/A
- P/E Ratio
- CPIX N/A
- AVTE N/A
- Revenue Growth
- CPIX N/A
- AVTE N/A
- 52 Week Low
- CPIX $1.04
- AVTE $1.25
- 52 Week High
- CPIX $7.25
- AVTE $32.42
- Technical
- Relative Strength Index (RSI)
- CPIX 43.04
- AVTE 52.00
- Support Level
- CPIX $3.91
- AVTE $2.44
- Resistance Level
- CPIX $4.47
- AVTE $2.56
- Average True Range (ATR)
- CPIX 0.36
- AVTE 0.09
- MACD
- CPIX -0.17
- AVTE 0.00
- Stochastic Oscillator
- CPIX 23.37
- AVTE 77.14
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.